Lawrence A. Yannuzzi
Elite in Late-Onset Retinal Degeneration
Elite in Late-Onset Retinal Degeneration
950 3rd Ave, 3rd floor, 
New York, NY 

Overview

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.

He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide.

Dr. Yannuzzi is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

His clinical research consists of co-authoring 200 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 66 articles in the study of Late-Onset Retinal Degeneration.

Residency
Ophthalmology Residency: Manhattan Eye, Ear & Throat Hospital
Specialties
Ophthalmology
Licenses
Specialist in NY
Languages Spoken
English
Gender
Male
Awards
America's Best Eye Doctor 2022 Award
An honorary doctorate by the University of Ancona
Michelson Award for Retinal Vascular Disease
Distinguished Alumnus Award by Boston University
Henkind Award
J. Donald M. Gass Lectureship
Patz Medals by The Macula Society
Alcon Research Award
Herman Wacker Award of the Club Jules Gonin
Arthur J. Bedelle Award
Retinal Research Award and the Gass Medal of the Retina Society
Bietti Medal
Pisart Award from the Lighthouse International
Lifetime Achievement Award by the American Academy of Ophthalmology

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Horizon Healthcare
  • EPO
  • POS
MetLife
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Vitreous Retina Macula Consultants Of New York
950 3rd Ave, 3rd floor, New York, NY 10022

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Similar Doctors
Richard F. Spaide
Elite in Late-Onset Retinal Degeneration
Ophthalmology
Elite in Late-Onset Retinal Degeneration
Ophthalmology

Vitreous Retina Macula Consultants Of New York(Downtown)

110 Lafayette St, Suite 502, 
New York, NY 
 (3.4 miles away)
Languages Spoken:
English

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.

Distinguished in Late-Onset Retinal Degeneration
Ophthalmology
Distinguished in Late-Onset Retinal Degeneration
Ophthalmology

University Physician Associates Of New Jersey Inc

150 Bergen St, 
Newark, NJ 
 (11.7 miles away)
Languages Spoken:
English

Marco Zarbin is an Ophthalmologist in Newark, New Jersey. Dr. Zarbin is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Endophthalmitis, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Jason S. Slakter
Distinguished in Late-Onset Retinal Degeneration
Ophthalmology
Distinguished in Late-Onset Retinal Degeneration
Ophthalmology

Vitreous Retina Macula Consultants Of New York

950 3rd Ave, 
New York, NY 
 (0.1 miles away)
Languages Spoken:
English

Dr. Slakter is a native of Los Angeles, California. He graduated from Pomona College in 1979 and was elected to Phi Beta Kappa fraternity and received his Doctor of Medicine degree from Albert Einstein College of Medicine in 1983 and was elected to Alpha Omega Alpha fraternity. He completed residency training in ophthalmology at the Manhattan Eye, Ear & Throat Hospital in 1987 and a year of fellowship training in medical and surgical retinal diseases also at Manhattan Eye, Ear & Throat Hospital in New York. Dr. Slakter is rated as a Distinguished provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Detachment, and Vitrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yannuzzi's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile